KUALA LUMPUR: Shares of PHARMANIAGA BHD [] fell to their lowest in nearly two months in morning trade today, despite the absence of any negative news.
At 10.59am, it was down 38 sen to RM4.12 with 2,000 shares done. This was the lowest since Oct 27.
RAM Rating Services had on Dec 8 lifted its ratings watch on the company's RM60 million Islamic debt notes programme and RM40 million commercial papers programme after its concession agreement with the Health Ministry was extended for another 10 years.
At RM4.12, Pharmaniaga is trading at a price-to-earnings ratio (PER) of 8.9 times compared with the pharmaceutical and bioTECHNOLOGY [] sector's average PER of 12.02 times.
Standard & Poor's had a hold recommendation on Pharmaniaga with a target price of RM4.60 in its report issued on Dec 7.
About Me
- Nuang
- Ibrahim bin Ramli@Nuang started his career with CIMB Wealth Advisors Berhad as Agency Manager in April, 2008.Previously he was an Internal Auditors and Accounts Executive with Perodua Sales Sdn Bhd since 17 August, 1994. His background:- 1.Certified of Achievement for Master Sales Leadership from Dr Lawrence Walter Ng of President of The Art Of Learning and International Of Learning Without Learning 2.Certified for eXtra Ordinary Performance of Lawrence Walter Award Certificate for One Million Ringgit Club 2007 3. Certified Life & General insurances 4. Conferred with Diploma in Business Studiess & Bachelor of Business Admin(Hons)Finance from UiTM, Terengganu Branch & Shah Alam respectively;
music
Create a playlist at MixPod.com
